YARTEMLEA Trademark

Trademark Overview


On Friday, September 8, 2023, a trademark application was filed for YARTEMLEA with the United States Patent and Trademark Office. The USPTO has given the YARTEMLEA trademark a serial number of 98171265. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, August 6, 2024. This trademark is owned by Omeros Corporation. The YARTEMLEA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of endothelial diseases and disorders, renal diseases, transplant complications, and hematological, neurological, immunological and inflammation-related disease and disorders; biologics for the treatment of endothelial diseases and disorders, renal diseases, transplant complications, and hematological, neurological, immunological and inflammation-related disease and disorders; preparations for diagnostic purposes are specifically excluded from all of the foregoing goods
yartemlea

General Information


Serial Number98171265
Word MarkYARTEMLEA
Filing DateFriday, September 8, 2023
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, August 6, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, June 11, 2024

Trademark Statements


Description of MarkThe mark consists of YARTEMLEA" in all capital letters. Three horizontally stacked waving lines, the top two of which are three times longer than the lowest line, are positioned above the last three letters of "YARTEMLEA" with the top two lines extending to the right of the word.
Goods and ServicesPharmaceutical preparations for the treatment of endothelial diseases and disorders, renal diseases, transplant complications, and hematological, neurological, immunological and inflammation-related disease and disorders; biologics for the treatment of endothelial diseases and disorders, renal diseases, transplant complications, and hematological, neurological, immunological and inflammation-related disease and disorders; preparations for diagnostic purposes are specifically excluded from all of the foregoing goods
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSunday, October 1, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameOmeros Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSeattle, WA 98119

Party NameOmeros Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSeattle, WA 98119

Trademark Events


Event DateEvent Description
Tuesday, September 12, 2023NEW APPLICATION ENTERED
Sunday, October 1, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, October 3, 2023NOTICE OF DESIGN SEARCH CODE E-MAILED
Friday, May 3, 2024ASSIGNED TO EXAMINER
Wednesday, May 22, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 11, 2024PUBLISHED FOR OPPOSITION
Monday, May 6, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 11, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 6, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT